In-vitro antibacterial, antifungal and cytotoxic properties of sulfonamide - Derived Schiff's bases and their metal complexes

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 20, Issue 2, 2005, Pages 183-188

  Chohan, Zahid H ^a   Mahmood Ul Hassan, ^b   Khan, Khalid M ^c   Supuran, Claudiu T ^d  

^a BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^b THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

^c UNIVERSITY OF KARACHI   (Pakistan)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antibacterial; Antifungal; Cytotoxicity; Metal complexes; Sulfonamides

Indexed keywords

AMPHOTERICIN B; COBALT COMPLEX; COPPER COMPLEX; IMIPENEM; MICONAZOLE; NICKEL COMPLEX; SCHIFF BASE; SULFONAMIDE; ZINC COMPLEX;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTEMIA; ARTICLE; ASPERGILLUS FLAVUS; BACILLUS CEREUS; BACTERIAL STRAIN; BIOASSAY; CANDIDA ALBICANS; CONTROLLED STUDY; CORYNEBACTERIUM DIPHTHERIAE; CYTOTOXICITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; FUSARIUM SOLANI; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MICROSPORUM CANIS; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; SHIGELLA DYSENTERIAE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; STRUCTURE ACTIVITY RELATION; TRICHOPHYTON;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ARTEMIA; BACTERIA; BIOLOGICAL ASSAY; LETHAL DOSE 50; METALS; MICROBIAL SENSITIVITY TESTS; MODELS, CHEMICAL; SCHIFF BASES; SULFONAMIDES;

ANOSTRACA; ASPERGILLUS FLAVUS; BACILLUS CEREUS; BACTERIA (MICROORGANISMS); CANDIDA; CANDIDA ALBICANS; CANIS; CORYNEBACTERIUM DIPHTHERIAE; DECAPODA (CRUSTACEA); ESCHERICHIA COLI; FUSARIUM; FUSARIUM SOLANI; KLEBSIELLA PNEUMONIAE; MICROSPORUM CANIS; MIRABILIS; NEGIBACTERIA; POSIBACTERIA; PROTEUS MIRABILIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; SHIGELLA; STAPHYLOCOCCUS; STREPTOCOCCUS PYOGENES; TRICHOPHYTON;

EID: 18444387141     PISSN: 14756366     EISSN: None     Source Type: Journal    
DOI: 10.1080/14756360500043257     Document Type: Article

References (40)

1. Domagk G. Deut Med Wochensch 1935;61:250-253.
2. Mandell GL, Petri WA. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman's and Gilman's the Pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill; 1996. p 1057-1072.
3. Drew J. Science 2000;287.
4. Owa T, Nagasu T. Exp Opin Ther Patents 2000;10:1725-1740.
5. Supuran CT, Scozzafava A. Exp Opin Ther Patents 2000; 10:575-600.
6. Supuran CT, Scozzafava A. Curr Med Chem-Imm., Endoc. Metab. Agents 2001;1:61-97.
7. Maren TH. Annu Rev Pharmacol Toxicol 1976;16:309-327.
8. Boyd AE. Diabetes 1988;37:847-850.
9. Thornber CW. Chem Soc Rev 1979;8:563-580.
10. Ogden RC, Flexner CW. Protease Inhibitors in AIDS Therapy. New York, U.S.A: Marcel Dekker; 2001.
11. Supuran CT, Scozzafava A, Mastrolorenzo A. Exp Opin Therap Patents 2001;11:221-259.
12. Scozzafava A, Supuran CT. J Med Chem 2000;43:3677-3687.
13. Brown CE, Towle JL. J Am Chem Soc 1941;63:3523.
14. Bult A. In: Sigel H, Sigel A, editors. Metal ions in biological systems. New York: M. Dekker; 1983. p 261-268, and references cited therein.
15. Supuran CT, Scozzafava A, Casini A. Med Res Rev 2003;23:146-189.
16. Alzuet G, Ferrer S, Borras J, Supuran CT. Roum Chem Quart Rev 1994;2:283-300.
17. Supuran CT, Manole G, Andruh M. J Inorg Biochem 1993;49:97-103.
18. Supuran CT. Rev Roum Chim 1992;37:849-855.
19. Sumalan SL, Casanova J, Alzuet G, Borras J, Castiñeiras A, Supuran CT. J Inorg Biochem 1996;62:31-39.
20. Supuran CT, Almajan GL. Main Group Met Chem 1995;18:347-351.
21. Supuran CT. Metal Based Drugs 1995;2:327-330.
22. Supuran CT, Scozzafava A. J Enz Inhib 1997;12:37-51.
23. Ul-Hassan M, Scozzafava A, Chohan ZH, Supuran CT. J Enz Inhib Med Chem 2001;16:499-505.
24. Ul-Hassan M, Scozzafava A, Chohan ZH, Supuran CT. J Enz Inhib Med Chem 2004;19:263.
25. Atta-ur-Rahman, Choudhary MI, Thomsen WJ. Bioassay Techniques for Drug Development. The Netherlands: Harwood Academic Publishers; 2001. p 16.
26. Khan KM, Rahat S, Choudhary MI, Atta-ur-Rahman, Ghani US, Perveen S, Khatoon A, Dar Malik A. Helv Chim Acta 2002;85:559.
27. Atta-ur-Rahman, Choudhary MI, Thomsen WJ. Bioassay techniques for drug development. The Netherlands: Harwood Academic Publishers; 2001. p 22.
28. McLaughlin JL, Chang C-J, Smith DL. In: Atta-ur-Rahman, editor. Studies in natural products chemistry, "BenchTop" bioassays for the discovery of bioactive natural products: An update, structure and chemistry (part-B). Vol. 9. The Netherlands: Elsevier Science Publishers B.V.; 1991. p 383.
29. Meyer BN, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DE, McLaughlin JL. Planta Medica 1982;45:31.
30. Finney DJ. Probit analysis. 3rd ed. Cambridge: Cambridge University Press; 1971.
31. Chohan ZH, Pervez H, Rauf A, Supuran CT. Metal-Based Drugs 2002;8:42.
32. Hassan MU, Chohan ZH, Supuran CT. Main Group Metal chemistry 2002;25:291.
33. Chohan ZH, Scozzafava A, Supuran CT. J Enz Inhib Med Chem 2003;18:259.
34. Chohan ZH, Scozzafava A, Supuran CT. J Enz Inhib Med Chem 2002;17(4):261.
35. Chohan ZH, Supuran CT, Scozzafava A. J Enz Inhib Med Chem 2003;18:1.
36. Chohan ZH. Synth React Inorg Met-Org Chem 2004;34:833.
37. Chohan ZH, Supuran CT, Scozzafava A. J Enz Inhib Med Chem 2004;19:79.
38. Chohan ZH, Khan KM, Supuran CT. Appl Organomet Chem 2004;18:305.
39. Chohan ZH, Scozzafava A, Supuran CT. Synth React Inorg Met-Org Chem 2003;33:241.
40. Chohan ZH, Pervez H, Scozzafava A, Supuran CT. J Chem Soc Pak 2003;25:308.